Logo image of ALISP.PA

ISPD NETWORK (ALISP.PA) Stock Fundamental Analysis

EPA:ALISP - Euronext Paris - Matif - ES0109429037 - Common Stock - Currency: EUR

2.76  0 (0%)

Fundamental Rating

3

Taking everything into account, ALISP scores 3 out of 10 in our fundamental rating. ALISP was compared to 67 industry peers in the Media industry. Both the profitability and financial health of ALISP have multiple concerns. ALISP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ALISP had negative earnings in the past year.
ALISP had a positive operating cash flow in the past year.
In multiple years ALISP reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALISP reported negative operating cash flow in multiple years.
ALISP.PA Yearly Net Income VS EBIT VS OCF VS FCFALISP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M

1.2 Ratios

With a Return On Assets value of -0.68%, ALISP is not doing good in the industry: 70.15% of the companies in the same industry are doing better.
The Return On Equity of ALISP (-13.52%) is worse than 71.64% of its industry peers.
With a decent Return On Invested Capital value of 7.10%, ALISP is doing good in the industry, outperforming 65.67% of the companies in the same industry.
ALISP had an Average Return On Invested Capital over the past 3 years of 21.85%. This is significantly above the industry average of 8.60%.
The 3 year average ROIC (21.85%) for ALISP is well above the current ROIC(7.10%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.68%
ROE -13.52%
ROIC 7.1%
ROA(3y)5.3%
ROA(5y)0.66%
ROE(3y)93.18%
ROE(5y)N/A
ROIC(3y)21.85%
ROIC(5y)N/A
ALISP.PA Yearly ROA, ROE, ROICALISP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 50 100 150

1.3 Margins

In the last couple of years the Profit Margin of ALISP has declined.
The Operating Margin of ALISP (1.09%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ALISP has declined.
ALISP's Gross Margin of 33.87% is on the low side compared to the rest of the industry. ALISP is outperformed by 70.15% of its industry peers.
ALISP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.09%
PM (TTM) N/A
GM 33.87%
OM growth 3Y39.74%
OM growth 5Y-18.2%
PM growth 3YN/A
PM growth 5Y-24.31%
GM growth 3Y0.14%
GM growth 5Y-5.93%
ALISP.PA Yearly Profit, Operating, Gross MarginsALISP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40 50

More info and screens

3

2. Health

2.1 Basic Checks

ALISP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
ALISP has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ALISP has been increased compared to 5 years ago.
ALISP has a better debt/assets ratio than last year.
ALISP.PA Yearly Shares OutstandingALISP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
ALISP.PA Yearly Total Debt VS Total AssetsALISP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

ALISP has an Altman-Z score of 2.57. This is not the best score and indicates that ALISP is in the grey zone with still only limited risk for bankruptcy at the moment.
ALISP's Altman-Z score of 2.57 is amongst the best of the industry. ALISP outperforms 86.57% of its industry peers.
The Debt to FCF ratio of ALISP is 7.33, which is on the high side as it means it would take ALISP, 7.33 years of fcf income to pay off all of its debts.
ALISP has a Debt to FCF ratio of 7.33. This is comparable to the rest of the industry: ALISP outperforms 47.76% of its industry peers.
ALISP has a Debt/Equity ratio of 1.49. This is a high value indicating a heavy dependency on external financing.
ALISP has a Debt to Equity ratio of 1.49. This is in the lower half of the industry: ALISP underperforms 62.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF 7.33
Altman-Z 2.57
ROIC/WACC0.95
WACC7.46%
ALISP.PA Yearly LT Debt VS Equity VS FCFALISP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

ALISP has a Current Ratio of 0.91. This is a bad value and indicates that ALISP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ALISP (0.91) is comparable to the rest of the industry.
A Quick Ratio of 0.91 indicates that ALISP may have some problems paying its short term obligations.
ALISP has a better Quick ratio (0.91) than 62.69% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.91
ALISP.PA Yearly Current Assets VS Current LiabilitesALISP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for ALISP have decreased strongly by -117.94% in the last year.
ALISP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.33% yearly.
Looking at the last year, ALISP shows a very strong growth in Revenue. The Revenue has grown by 27.55%.
Measured over the past years, ALISP shows a very strong growth in Revenue. The Revenue has been growing by 36.52% on average per year.
EPS 1Y (TTM)-117.94%
EPS 3YN/A
EPS 5Y-20.33%
EPS Q2Q%-600.8%
Revenue 1Y (TTM)27.55%
Revenue growth 3Y37.03%
Revenue growth 5Y36.52%
Sales Q2Q%18.78%

3.2 Future

ALISP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.86% yearly.
Based on estimates for the next years, ALISP will show a quite strong growth in Revenue. The Revenue will grow by 9.78% on average per year.
EPS Next Y-129.27%
EPS Next 2Y14.76%
EPS Next 3Y31.86%
EPS Next 5YN/A
Revenue Next Year27.36%
Revenue Next 2Y16.43%
Revenue Next 3Y12.45%
Revenue Next 5Y9.78%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALISP.PA Yearly Revenue VS EstimatesALISP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
ALISP.PA Yearly EPS VS EstimatesALISP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 0.2 0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ALISP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ALISP is valuated reasonably with a Price/Forward Earnings ratio of 9.92.
Based on the Price/Forward Earnings ratio, ALISP is valued a bit cheaper than 65.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. ALISP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 9.92
ALISP.PA Price Earnings VS Forward Price EarningsALISP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

ALISP's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALISP is more expensive than 68.66% of the companies in the same industry.
ALISP's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 17.13
EV/EBITDA 19.35
ALISP.PA Per share dataALISP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as ALISP's earnings are expected to grow with 31.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.76%
EPS Next 3Y31.86%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALISP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ISPD NETWORK

EPA:ALISP (3/7/2025, 7:00:00 PM)

2.76

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)07-24 2024-07-24
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap41.10M
Analysts86.67
Price Target5.36 (94.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-135.29%
EPS NY rev (3m)-135.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)5.28%
Revenue NY rev (3m)5.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.92
P/S 0.27
P/FCF 17.13
P/OCF 9.58
P/B 11.56
P/tB N/A
EV/EBITDA 19.35
EPS(TTM)-0.03
EYN/A
EPS(NY)0.28
Fwd EY10.08%
FCF(TTM)0.16
FCFY5.84%
OCF(TTM)0.29
OCFY10.44%
SpS10.13
BVpS0.24
TBVpS-0.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.68%
ROE -13.52%
ROCE 9.82%
ROIC 7.1%
ROICexc 11.44%
ROICexgc N/A
OM 1.09%
PM (TTM) N/A
GM 33.87%
FCFM 1.59%
ROA(3y)5.3%
ROA(5y)0.66%
ROE(3y)93.18%
ROE(5y)N/A
ROIC(3y)21.85%
ROIC(5y)N/A
ROICexc(3y)254.41%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)30.22%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y83.3%
ROICexc growth 5Y18.96%
OM growth 3Y39.74%
OM growth 5Y-18.2%
PM growth 3YN/A
PM growth 5Y-24.31%
GM growth 3Y0.14%
GM growth 5Y-5.93%
F-Score4
Asset Turnover2.13
Health
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF 7.33
Debt/EBITDA 1.96
Cap/Depr 178.83%
Cap/Sales 1.25%
Interest Coverage 1.65
Cash Conversion 158.72%
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.91
Altman-Z 2.57
F-Score4
WACC7.46%
ROIC/WACC0.95
Cap/Depr(3y)93.32%
Cap/Depr(5y)73.86%
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-117.94%
EPS 3YN/A
EPS 5Y-20.33%
EPS Q2Q%-600.8%
EPS Next Y-129.27%
EPS Next 2Y14.76%
EPS Next 3Y31.86%
EPS Next 5YN/A
Revenue 1Y (TTM)27.55%
Revenue growth 3Y37.03%
Revenue growth 5Y36.52%
Sales Q2Q%18.78%
Revenue Next Year27.36%
Revenue Next 2Y16.43%
Revenue Next 3Y12.45%
Revenue Next 5Y9.78%
EBIT growth 1Y-68.7%
EBIT growth 3Y91.48%
EBIT growth 5Y11.67%
EBIT Next Year-15.17%
EBIT Next 3Y26.18%
EBIT Next 5YN/A
FCF growth 1Y212.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15012.3%
OCF growth 3YN/A
OCF growth 5YN/A